Additional value of spirometry in risk assessment of acute respiratory disease in winter among patients with mild to moderate asthma or COPD

S. van Loon, A. P. Sachs, T. J. Verheij, E. Hak (Utrecht, The Netherlands)

Source: Annual Congress 2002 - Aspects of respiratory disease in primary care
Session: Aspects of respiratory disease in primary care
Session type: Thematic Poster Session
Number: 2983
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. van Loon, A. P. Sachs, T. J. Verheij, E. Hak (Utrecht, The Netherlands). Additional value of spirometry in risk assessment of acute respiratory disease in winter among patients with mild to moderate asthma or COPD. Eur Respir J 2002; 20: Suppl. 38, 2983

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007



COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016

COPD incidence in subjects with risk factors, chronic respiratory symptoms and normal spirometry: The PLATINO study>
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006


Impact of moderate and severe exacerbations in severe COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Is high level of IgE an additional problem in smoking patients with severe and very severe chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012

Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021



Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Source: Eur Respir J 2002; 19: 398-404
Year: 2002



Can seriousness of respiratory failure be predicted by the values of clinical score in patients with acute severe asthma?
Source: Eur Respir J 2001; 18: Suppl. 33, 73s
Year: 2001

The minimal clinical important difference of the severe respiratory insufficiency questionnaire in stable hypercapnic COPD patients on chronic NIV.
Source: Virtual Congress 2020 – Non-invasive ventilation during acute and chronic respiratory failure: technical aspects, adherence and effects
Year: 2020


β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011

Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018



An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


The risk of hyperkalemia in COPD and asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

GOLDs definition of COPD in a Norwegian community by self-reported clinical diagnosis of obstructive lung disease and respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002

Socioeconomic risk factors for COPD and respiratory symptoms in a general population
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007